Experience of the department of surgical treatment of bone and soft tissue tumors during COVID-19 pandemic period

Since December 2019 the new coronavirus disease (COVID-19) has hit the world, causing the World Health Organization to declare it a pandemic. With the emergence and spread of the new infection, there has been unprecedented pressure on health care systems around the world. The time constraints associ...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Artem V. Bukharov, Vitalii A. Derzhavin, Anna V. Yadrina, Dmtrii A. Erin
Formato:	article
Lenguaje:	RU
Publicado:	IP Habib O.N. 2021
Materias:	coronavirus infection oncology pandemic sarcoma pneumonia computed tomography oncoorthopedic pathology Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/8d98bd758850497385107f4fa404e5be
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8d98bd758850497385107f4fa404e5be
record_format	dspace
spelling	oai:doaj.org-article:8d98bd758850497385107f4fa404e5be2021-11-30T16:55:01ZExperience of the department of surgical treatment of bone and soft tissue tumors during COVID-19 pandemic period1815-14341815-144210.26442/18151434.2021.2.200735https://doaj.org/article/8d98bd758850497385107f4fa404e5be2021-08-01T00:00:00Zhttps://modernonco.orscience.ru/1815-1434/article/viewFile/59612/pdfhttps://doaj.org/toc/1815-1434https://doaj.org/toc/1815-1442Since December 2019 the new coronavirus disease (COVID-19) has hit the world, causing the World Health Organization to declare it a pandemic. With the emergence and spread of the new infection, there has been unprecedented pressure on health care systems around the world. The time constraints associated with receiving routine care also affected the risk group cancer patients, as some hospitals were quarantined. Violation of the terms of both systemic drug, radiation and surgical treatment of cancer patients could lead to the progression of the tumor process and lead to the death of the patient. In connection with the current situation, doctors had to quickly change the tactics of managing cancer patients, due to the lack of accurate data on the basis of which it is possible to determine the optimal approach to the use of therapy, they had to make decisions in conditions of lack of data. The article shows an example of the treatment of 113 patients being treated in the department of surgical treatment of bone and soft tissue tumors in National Medical Research Radiological Center of the Ministry of Health of Russia during the first wave of the pandemic from March 30 to July 1, 2020. Surgical treatment was performed in 103 patients. During the period of stay in the hospital, 11 patients showed signs of coronavirus infection. Of these, 10 patients were diagnosed with coronavirus infection in the postoperative period. According to the study, the nosocomial incidence of COVID-19 is 10%. With timely diagnosis and specialized treatment, the survival rate was 100% in the given example. Consequently, if epidemiological measures are observed at all stages of hospitalization, it is possible to carry out planned surgical treatment for patients with primary and secondary lesions of bones and soft tissues. However, the decision to carry out a planned operation during a pandemic should be individual for each patient.Artem V. BukharovVitalii A. DerzhavinAnna V. YadrinaDmtrii A. ErinIP Habib O.N.articlecoronavirus infectiononcologypandemicsarcomapneumoniacomputed tomographyoncoorthopedic pathologyNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282RUСовременная онкология, Vol 23, Iss 2, Pp 260-262 (2021)
institution	DOAJ
collection	DOAJ
language	RU
topic	coronavirus infection oncology pandemic sarcoma pneumonia computed tomography oncoorthopedic pathology Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	coronavirus infection oncology pandemic sarcoma pneumonia computed tomography oncoorthopedic pathology Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Artem V. Bukharov Vitalii A. Derzhavin Anna V. Yadrina Dmtrii A. Erin Experience of the department of surgical treatment of bone and soft tissue tumors during COVID-19 pandemic period
description	Since December 2019 the new coronavirus disease (COVID-19) has hit the world, causing the World Health Organization to declare it a pandemic. With the emergence and spread of the new infection, there has been unprecedented pressure on health care systems around the world. The time constraints associated with receiving routine care also affected the risk group cancer patients, as some hospitals were quarantined. Violation of the terms of both systemic drug, radiation and surgical treatment of cancer patients could lead to the progression of the tumor process and lead to the death of the patient. In connection with the current situation, doctors had to quickly change the tactics of managing cancer patients, due to the lack of accurate data on the basis of which it is possible to determine the optimal approach to the use of therapy, they had to make decisions in conditions of lack of data. The article shows an example of the treatment of 113 patients being treated in the department of surgical treatment of bone and soft tissue tumors in National Medical Research Radiological Center of the Ministry of Health of Russia during the first wave of the pandemic from March 30 to July 1, 2020. Surgical treatment was performed in 103 patients. During the period of stay in the hospital, 11 patients showed signs of coronavirus infection. Of these, 10 patients were diagnosed with coronavirus infection in the postoperative period. According to the study, the nosocomial incidence of COVID-19 is 10%. With timely diagnosis and specialized treatment, the survival rate was 100% in the given example. Consequently, if epidemiological measures are observed at all stages of hospitalization, it is possible to carry out planned surgical treatment for patients with primary and secondary lesions of bones and soft tissues. However, the decision to carry out a planned operation during a pandemic should be individual for each patient.
format	article
author	Artem V. Bukharov Vitalii A. Derzhavin Anna V. Yadrina Dmtrii A. Erin
author_facet	Artem V. Bukharov Vitalii A. Derzhavin Anna V. Yadrina Dmtrii A. Erin
author_sort	Artem V. Bukharov
title	Experience of the department of surgical treatment of bone and soft tissue tumors during COVID-19 pandemic period
title_short	Experience of the department of surgical treatment of bone and soft tissue tumors during COVID-19 pandemic period
title_full	Experience of the department of surgical treatment of bone and soft tissue tumors during COVID-19 pandemic period
title_fullStr	Experience of the department of surgical treatment of bone and soft tissue tumors during COVID-19 pandemic period
title_full_unstemmed	Experience of the department of surgical treatment of bone and soft tissue tumors during COVID-19 pandemic period
title_sort	experience of the department of surgical treatment of bone and soft tissue tumors during covid-19 pandemic period
publisher	IP Habib O.N.
publishDate	2021
url	https://doaj.org/article/8d98bd758850497385107f4fa404e5be
work_keys_str_mv	AT artemvbukharov experienceofthedepartmentofsurgicaltreatmentofboneandsofttissuetumorsduringcovid19pandemicperiod AT vitaliiaderzhavin experienceofthedepartmentofsurgicaltreatmentofboneandsofttissuetumorsduringcovid19pandemicperiod AT annavyadrina experienceofthedepartmentofsurgicaltreatmentofboneandsofttissuetumorsduringcovid19pandemicperiod AT dmtriiaerin experienceofthedepartmentofsurgicaltreatmentofboneandsofttissuetumorsduringcovid19pandemicperiod
_version_	1718406458198982656

Experience of the department of surgical treatment of bone and soft tissue tumors during COVID-19 pandemic period

Ejemplares similares